QLT is a biotechnology company dedicated to the development and commercialization of ocular products.
Dr. Anido previously served as president, CEO and a director of Ista Pharmaceuticals, which was recently acquired by Bausch & Lomb.
Prior to this position, Dr. Anido held positions with Windamere Venture Partners, CombiChem and the Americas Region of Allergan.
QLT is headquartered in Vancouver, Canada.
Related Articles on Ophthalmology:
Miami’s Bascom Palmer Eye Institute Ranked #1 Ophthalmology Program by U.S. News
Ophthalmologist William De La Peña to Serve on UCSF Advisory Board
tudy: Risk for Retinal Detachment After Phacoemulsification Declines
